At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
RKDA Arcadia Biosciences
Trading 10-19 09:50:56 EDT
0.1403
-0.0245
-14.87%
High0.1599Low0.1116Vol307.02K
Open0.1565D1 Closing0.1648Amplitude29.31%
Mkt Cap338.01KTradable Cap304.18KTotal Shares2.41M
T/O41.70KT/O Rate14.16%Tradable Shares2.17M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Arcadia Biosciences Shareholders Approve Governance and Capital Moves
TIPRANKS  ·  09-16
Arcadia Biosciences Shareholders Approve Governance and Capital Moves
Arcadia Biosciences Annual Meeting Drew 52.3% of Outstanding Shares Represented
Reuters  ·  09-16
Arcadia Biosciences Annual Meeting Drew 52.3% of Outstanding Shares Represented
Arcadia Biosciences Receives Nasdaq Listing Compliance Notice
TIPRANKS  ·  09-05
Arcadia Biosciences Receives Nasdaq Listing Compliance Notice
Arcadia Biosciences Gets NASDAQ Notice for Falling Below $2.5 Million Stockholders’ Equity Requirement
Reuters  ·  09-05
Arcadia Biosciences Gets NASDAQ Notice for Falling Below $2.5 Million Stockholders’ Equity Requirement
Arcadia Biosciences Q2 EPS $(2.09) Up From $(3.26) YoY, Sales $1.443M Down From $1.455M YoY
Benzinga Earnings  ·  08-14
Arcadia Biosciences Q2 EPS $(2.09) Up From $(3.26) YoY, Sales $1.443M Down From $1.455M YoY
Arcadia Biosciences Q2 FY26 Net Loss Widens 41% to $6.27 Million; Revenue Slips 1% to $1.44 Million
Reuters  ·  08-14
Arcadia Biosciences Q2 FY26 Net Loss Widens 41% to $6.27 Million; Revenue Slips 1% to $1.44 Million
Arcadia Biosciences Q2 Net Income USD -6.266 Million
Reuters  ·  08-14
Arcadia Biosciences Q2 Net Income USD -6.266 Million
Arcadia Biosciences Q2 EPS USD -2.09
THOMSON REUTERS  ·  08-14
Arcadia Biosciences Q2 EPS USD -2.09
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
GlobeNewswire  ·  08-14
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
Arcadia Biosciences Gets NASDAQ Notice for Failing $1 Minimum Bid Price Rule
Reuters  ·  08-10
Arcadia Biosciences Gets NASDAQ Notice for Failing $1 Minimum Bid Price Rule
Arcadia Biosciences Announces Annual Shareholder Meeting
Reuters  ·  08-01
Arcadia Biosciences Announces Annual Shareholder Meeting
Arcadia Biosciences Awards CEO Thomas Schaefer $169,000 Discretionary Cash Bonus for 2025
Reuters  ·  07-03
Arcadia Biosciences Awards CEO Thomas Schaefer $169,000 Discretionary Cash Bonus for 2025
Arcadia Biosciences files to sell 11.92M shares of common stock for holders
TIPRANKS  ·  06-27
Arcadia Biosciences files to sell 11.92M shares of common stock for holders
Arcadia Biosciences Announces $4 Million Private Placement
TIPRANKS  ·  06-15
Arcadia Biosciences Announces $4 Million Private Placement
Arcadia Biosciences (Rkda) Announces Closing of $4 Million Private Placement Priced at-the-Market Under Nasdaq Rules
THOMSON REUTERS  ·  06-13
Arcadia Biosciences (Rkda) Announces Closing of $4 Million Private Placement Priced at-the-Market Under Nasdaq Rules
Arcadia Biosciences prices USD 4 million at-the-market private placement at USD 1.03 per share
Reuters  ·  06-12
Arcadia Biosciences prices USD 4 million at-the-market private placement at USD 1.03 per share
Press Release: Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Dow Jones  ·  06-12
Press Release: Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Top News Today: Stocks Fall, Treasury Yields Rise on Inflation Fears
Dow Jones  ·  05-20
Top News Today: Stocks Fall, Treasury Yields Rise on Inflation Fears
Arcadia Biosciences Q1 EPS $(2.11) Misses $(0.80) Estimate, Sales $1.100M Miss $1.600M Estimate
Benzinga Earnings  ·  05-15
Arcadia Biosciences Q1 EPS $(2.11) Misses $(0.80) Estimate, Sales $1.100M Miss $1.600M Estimate
Arcadia Biosciences Q1 FY26 net loss widens to $4.39 million; revenue falls 8% to $1.1 million
Reuters  ·  05-15
Arcadia Biosciences Q1 FY26 net loss widens to $4.39 million; revenue falls 8% to $1.1 million

Introduction

Company Name.
Arcadia Biosciences
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Issue price:
--